Cargando…
Effect of Sirolimus/Metformin Co-Treatment on Hyperglycemia and Cellular Respiration in BALB/c Mice
Sirolimus (SRL) is widely used as an immunosuppressant to prevent graft rejection, despite the risk of impairing glucose metabolism. Metformin (MET) can reduce the detrimental effects of SRL in many patients, including diabetes and renal transplant recipients. Limited in vivo studies have reported o...
Autores principales: | Albawardi, Alia, Saraswathiamma, Dhanya, Sharma, Charu, Elomami, Abdulghani, Souid, Abdul-Kader, Almarzooqi, Saeeda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866855/ https://www.ncbi.nlm.nih.gov/pubmed/36674739 http://dx.doi.org/10.3390/ijms24021223 |
Ejemplares similares
-
Lower Prevalence of Human Papillomavirus in Head and Neck Squamous Cell Carcinoma in Middle Eastern Population: Clinical Implications for Diagnosis and Prevention
por: Almarzooqi, Saeeda, et al.
Publicado: (2023) -
Effects of molecularly targeted therapies on murine thymus: highly selective mTOR inhibitors induce reversible thymic involution
por: Al-Hammadi, Suleiman, et al.
Publicado: (2016) -
A preparation of murine liver fragments for in vitro studies: liver preparation for toxicological studies
por: Alfazari, Ali S, et al.
Publicado: (2013) -
Bioenergetic study of murine hepatic tissue treated in vitro with atorvastatin
por: Alfazari, Ali S, et al.
Publicado: (2013) -
In vitro assessment of antitumor activities of the PI3K/mTOR inhibitor GSK2126458
por: Albawardi, Alia, et al.
Publicado: (2014)